Get started
Author

E. E. Vaiman

Observed names: E. E. Vayman, E.E. Vaiman, Elena E. Vaiman, Elena Vaiman, Elena Vayman, Elene E. Vaiman, Вайман Е. Э., Вайман Елена Эдуардовна, Е А Вайман, Е.Э. Вайман, Елена Эдуардовна Вайман
ORCID: 0000-0001-6836-9590
Observed ORCID: 0000-0001-6836-9590
OpenAlex ID: A5082473823
Cytokine Imbalance as a Biomarker of Intervertebral Disk Degeneration
2023 · Natalia A. Shnayder, Azamat V. Ashhotov, et al. · International Journal of Molecular Sciences · 53
PDF
Genetic Factors of Nitric Oxide’s System in Psychoneurologic Disorders
2020 · Regina F. Nasyrova, Polina V. Moskaleva, et al. · International Journal of Molecular Sciences · 39
Pathophysiological Mechanisms of Antipsychotic-Induced Parkinsonism
2022 · Elena Vaiman, Natalia Shnayder, et al. · Biomedicines · 29
PDF
Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
2021 · Elena E. Vaiman, Natalia A. Shnayder, et al. · Biomedicines · 17
PDF
Pharmacogenetics of chlorpromazine and its role in the development of antipsychotic-induced parkinsonism
2021 · E. E. Vaiman, M. A. Novitsky, et al. · Personalized Psychiatry and Neurology · 11
PDF
Role of Pharmacokinetics and Pharmacogenetics of Antidepressant-Induced Prolongation of the QT Interval and Torsade de Pointes in Patients with Mental Disorders
2023 · N. A. Shnayder, A. V. Kidyaeva, et al. · Personalized Psychiatry and Neurology · 9
PDF
Single-Nucleotide Polymorphisms as Biomarkers of Antipsychotic-Induced Akathisia: Systematic Review
2023 · Regina F. Nasyrova, Elena E. Vaiman, et al. · Genes · 8
PDF
Genetic Biomarkers of Antipsychotic-Induced Prolongation of the QT Interval in Patients with Schizophrenia
2022 · Elena E. Vaiman, Natalia A. Shnayder, et al. · International Journal of Molecular Sciences · 7
PDF
Interindividual Variability of Anticonvulsant-Induced QT Prolongation Risk
2022 · N. M. Zhuravlev, N. A. Shnayder, et al. · Personalized Psychiatry and Neurology · 7
PDF
Association of a Single-Nucleotide Variant rs11100494 of the NPY5R Gene with Antipsychotic-Induced Metabolic Disorders
2022 · Vera S. Dobrodeeva, Natalia A. Shnayder, et al. · Pharmaceutics · 7
PDF
The Role of Single Nucleotide Variants of NOS1, NOS2, and NOS3 Genes in the Development of the Phenotype of Migraine and Arterial Hypertension
2021 · Polina V. Moskaleva, Natalya A. Shnayder, et al. · Brain Sciences · 7
PDF
Pathophysiological mechanisms underlying antipsychotic-induced tardive dyskinesia
2020 · E. E. Vayman, N. A. Shnayder, et al. · Bulletin of Siberian Medicine · 7
PDF
Antipsychotic-induced tardive dyskinesia as a serious adverse effect in the psychopharmacotherapy of schizophrenia
2019 · E. E. Vaiman, N. A. Shnayder, et al. · Neurology neuropsychiatry Psychosomatics · 7
PDF
Antipsychotic-Induced Parkinsonism: A Risk Assessment Scale and Personalised Diagnosis Algorithm
2024 · N. A. Shnayder, E. E. Vaiman, et al. · Safety and Risk of Pharmacotherapy · 6
Association of the ACTN3 Gene’s Single-Nucleotide Variant Rs1815739 (R577X) with Sports Qualification and Competitive Distance in Caucasian Athletes of the Southern Urals
2023 · Olga V. Balberova, Natalia A. Shnayder, et al. · Genes · 5
PDF
Antipsychotic-Induced Parkinsonism and Dyskinesia in a 43- years Old Male with Schizophrenia: Clinical Case
2023 · E. E. Vaiman, L. P. Linova · Personalized Psychiatry and Neurology · 4
PDF
Методы диагностики лекарственно-индуцированного паркинсонизма: обзор отечественной и зарубежной литературы
2020 · Е.Э. Вайман, Н.А. Шнайдер, et al. · Сибирский вестник психиатрии и наркологии · 4
PDF
Candidate genes involved in the development of antipsychotic-induced tardive dyskinesia in patients with schizophrenia
2020 · E. E. Vaiman, N. A. Shnayder, et al. · Neuromuscular Diseases · 4
PDF
Candidate genes of the development of antipsychotic-induced parkinsonism in patients with schizophrenia
2021 · E. E. Vaiman, N. A. Shnayder, et al. · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · 3
PDF
Pharmacogenomics of hyaluronic acid
2021 · Elena E. Vaiman, Natalia A. Shnayder, et al. · Vestnik dermatologii i venerologii · 3
PDF
Pharmacogenetic aspects of the dopaminergic system in clozapine pharmacodynamics
2020 · V.V. Kravtsov, I.A. Filippov, et al. · S S Korsakov Journal of Neurology and Psychiatry · 3
Predictive Pharmacogenetic Testing in Psychiatry: Pros and Cons
2024 · A. Yu. Avilov, A. V. Kidyaeva, et al. · Personalized Psychiatry and Neurology · 2
PDF
Влияние однонуклеотидных вариантов генов серотонинергической системы на возникновение проявлений терапевтической резистентности у больных шизофренией
2023 · Е.Э. Вайман, М.А. Тумова, et al. · Сибирский вестник психиатрии и наркологии · 2
PDF
Possible Clinical and Pharmacogenetic Predictors of the Efficacy and Safety of Carbamazepine in Post-COVID-19 Depression.
2022 · Elena Vaiman, Arseny Gayduk, et al. · PubMed · 2
Genetic aspects of primary headaches in Siberia (Russia)
2021 · A. V. Kondratiev, N. A. Shnayder, et al. · Personalized Psychiatry and Neurology · 2
PDF
Works count: 40
Citation count: 254
H-index: 7
I10-index: 5
Year
Topic
Type